Liquidity Services Announces Retirement of Patrick W. Gross

Liquidity Services Announces Retirement of Patrick W. Gross

Beatriz Infante Elected as New Lead Independent Director......

Worthington Industries Announces Leadership Teams for New

Worthington Industries Announces Leadership Teams for New

COLUMBUS, Ohio, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Worthington Industries, Inc. (NYSE: WOR), a leading industrial manufacturing company, today announced......

Hub Group, Inc. Reports Fourth Quarter and Full Year 2022

Hub Group, Inc. Reports Fourth Quarter and Full Year 2022

Highlights: Diluted earnings per share (EPS) of $2.42 for the quarter, and $10.64 for the full year which is growth of 110%Full year revenue of $5.3......

GA-ASI Flight Tests LEO SATCOM on MQ-9A

GA-ASI Flight Tests LEO SATCOM on MQ-9A

Capability Provides Global Coverage That Enables Operations Anywhere in the World......

GA-ASI Selected to Build OBSS for AFRL

GA-ASI Selected to Build OBSS for AFRL

SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- General Atomics Aeronautical Systems, Inc. (GA-ASI) will manufacture and perform demonstration flights of......

BitFrontier Capital Holdings, Inc. Announces Signing of

BitFrontier Capital Holdings, Inc. Announces Signing of

CRESTVIEW, FL, Feb. 02, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BitFrontier Capital Holdings, Inc. (OTC: BFCH) is pleased to announce it has signed a......

Silo Pharma Announces Expansion of Intellectual Property

Silo Pharma Announces Expansion of Intellectual Property

Silo Receives Issuance of U.S. Patent Covering SPC-15 Method for Treatment and Prevention of Stress-Induced Affective Disorders......

Surface Oncology to Participate in the 2023 Guggenheim

Surface Oncology to Participate in the 2023 Guggenheim

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation......

Reneo Pharmaceuticals to Participate in SVB Securities

Reneo Pharmaceuticals to Participate in SVB Securities

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the......

Revolution Medicines to Participate in Upcoming Investor

Revolution Medicines to Participate in Upcoming Investor

REDWOOD CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted......

  • 1
  • ...
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • menu
    menu